X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
index medicus (13) 13
male (9) 9
female (8) 8
gastroenterology & hepatology (8) 8
adolescent (4) 4
animals (4) 4
child (4) 4
italy (4) 4
middle aged (4) 4
adult (3) 3
aged (3) 3
apoptosis - drug effects (3) 3
body mass index (3) 3
body-mass index (3) 3
cancer (3) 3
cell proliferation - drug effects (3) 3
child, preschool (3) 3
crohn's disease (3) 3
gerd (3) 3
mice (3) 3
obesity (3) 3
physiological aspects (3) 3
severity of illness index (3) 3
symptoms (3) 3
analysis (2) 2
angiogenic factors (2) 2
apoptosis (2) 2
b16f10 cells (2) 2
case-control studies (2) 2
children (2) 2
colonoscopy (2) 2
complications (2) 2
downstream effectors (2) 2
endocrinology & metabolism (2) 2
esophagitis, peptic - etiology (2) 2
esophagitis, peptic - pathology (2) 2
esophagoscopy (2) 2
esophagus - pathology (2) 2
follow-up studies (2) 2
fungi (2) 2
gastroesophageal reflux - epidemiology (2) 2
gastroesophageal reflux - etiology (2) 2
gastroesophageal reflux - pathology (2) 2
gastroesophageal reflux disease (2) 2
gastroesophageal-reflux disease (2) 2
genetics & heredity (2) 2
gold compounds (2) 2
health aspects (2) 2
heartburn - epidemiology (2) 2
heartburn - etiology (2) 2
heartburn - pathology (2) 2
history (2) 2
inhibitors (2) 2
insulin (2) 2
lymph nodes (2) 2
metabolism (2) 2
mortality (2) 2
obesity - physiopathology (2) 2
sense organs (2) 2
surveys and questionnaires (2) 2
therapy (2) 2
treatment outcome (2) 2
ultrasound (2) 2
weight-loss (2) 2
2,2'-dipyridyl - chemistry (1) 1
48-h acid reflux monitoring (1) 1
48‐h acid reflux monitoring (1) 1
abdominal pain - etiology (1) 1
abdominal pain - physiopathology (1) 1
acg guidelines (1) 1
acid suppression (1) 1
adducts (1) 1
adenine - analogs & derivatives (1) 1
adenine - toxicity (1) 1
adiponectin (1) 1
adipose-tissue (1) 1
adolescence (1) 1
adolescents (1) 1
adrenergic beta-3 receptor antagonists - administration & dosage (1) 1
adrenergic beta-3 receptor antagonists - pharmacology (1) 1
adrenergic transmission (1) 1
adrenergic-receptor (1) 1
adult obesity (1) 1
advance care (1) 1
advance care planning (1) 1
age (1) 1
age distribution (1) 1
aged, 80 and over (1) 1
alembert, jean le rond d', 1717-1783 (1) 1
alpha-ketoglutarate-dependent dioxygenase fto (1) 1
analgesics, opioid - therapeutic use (1) 1
anesthesia (1) 1
angiogenesis (1) 1
angiogenesis inhibitors - pharmacology (1) 1
anti-vegf (1) 1
anticancer (1) 1
antineoplastic agents - pharmacology (1) 1
antipsychotic agents - therapeutic use (1) 1
api-023 (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Digestive and Liver Disease, ISSN 1590-8658, 09/2019, Volume 51, Issue 9, pp. 1209 - 1213
Gut microbial dysbiosis is considered an alteration of diversity and abundance of intestinal microbes, which contributes to the onset of many disorders.... 
Probiotics | Dysbiosis | Colonoscopy | Gut Microbiota | PERMEABILITY | INTESTINAL MICROBIOTA | INFLAMMATION | DISEASE | COMPLICATIONS | HEALTH | GASTROENTEROLOGY & HEPATOLOGY | KEY
Journal Article
Journal Article
Journal Article
Cellular Physiology and Biochemistry, ISSN 1015-8987, 10/2017, Volume 42, Issue 5, pp. 1725 - 1738
Journal Article
Inorganic Chemistry, ISSN 0020-1669, 02/2019, Volume 58, Issue 3, pp. 2140 - 2148
Following our recent reports on the inhibition of the water and glycerol channel aquaglyceroporin-3 (AQP3) by the coordination complex... 
ANTICANCER | CHANNEL | OPPORTUNITIES | SELECTIVITY | GOLD COMPOUNDS | WATER | CHEMISTRY, INORGANIC & NUCLEAR
Journal Article
Journal of Virology, ISSN 0022-538X, 05/2016, Volume 90, Issue 10, pp. 5205 - 5209
Journal Article
Expert Review of Gastroenterology & Hepatology, ISSN 1747-4124, 02/2018, Volume 12, Issue 2, pp. 119 - 124
Introduction: Endoscopy has a key role in the management of inflammatory bowel disease (IBD). It is helpful in the diagnosis, in case of relapse,... 
bowel preparation | endoscopy | sedation | inflammatory bowel disease | Ulcerative colitis | crohn's disease | crohn’s disease | QUALITY | METAANALYSIS | EFFICACY | OUTPATIENT COLONOSCOPY | PERFORMANCE | SPLIT | UNSEDATED COLONOSCOPY | IMPACT | GASTROINTESTINAL ENDOSCOPY | POLYETHYLENE-GLYCOL | GASTROENTEROLOGY & HEPATOLOGY
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 2159 - 2159
Abstract Purpose: The aim of this multi-centre study was to retrospectively assess in thalassemia major (TM) if deferiprone (DFP) had a dose-dependent effect... 
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2008, Volume 14, Issue 34, pp. 5233 - 5236
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 09/2011, Volume 1232, Issue 1, pp. 114 - 139
The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48‐h pH monitoring,... 
functional heartburn | CMA omeprazole | erosive esophigitis | API‐023 | functional dyspepsia | tenatoprazole | NERD | ilaprazole | ACG guidelines | GABAB | Symptom Association Probability | bile acids | AspECT trial | Barrett's esophagus | rabeprazole | Bilitec probe | 48‐h acid reflux monitoring | Clostridium difficile | COX‐2 inhibitors | baclofen | TLESR | STU‐Na | PPI therapy | GERD | fundic glands polyp | nocturnal acid breakthrough | dexlansoprazole | pH testing | acid suppression | pharmacokinetic changes | COX-2 inhibitors | STU-Na | Pharmacokinetic changes | Tenatoprazole | Rabeprazole | API-023 | Fundic glands polyp | Nocturnal acid breakthrough | Baclofen | Functional heartburn | Acid suppression | Dexlansoprazole | Bile acids | PH testing | 48-h acid reflux monitoring | Functional dyspepsia | Erosive esophigitis | Ilaprazole | COMPETITIVE ACID BLOCKER | IMMEDIATE-RELEASE OMEPRAZOLE | SPHINCTER RELAXATIONS | GABA(B) | GASTROESOPHAGEAL-REFLUX DISEASE | DEXLANSOPRAZOLE MR | GABA(B) AGONIST BACLOFEN | MULTIDISCIPLINARY SCIENCES | MULTICHANNEL INTRALUMINAL IMPEDANCE | BODY-MASS INDEX | HEALTHY-VOLUNTEERS | GASTROENTEROLOGY & HEPATOLOGY | Treatment Outcome | Monitoring, Physiologic | Proton Pump Inhibitors - therapeutic use | Barrett Esophagus - drug therapy | Chemoprevention | Humans | Gastroesophageal reflux | Medical colleges | Prokinetic agents | Deoxycholic acid | Prevention | Omeprazole | Gastrointestinal diseases | GABA | Cancer | Side effects | Nonsteroidal anti-inflammatory drugs | Drugs | Obesity | Inhibitors | Pumps | Segments | Monitoring | Esophagus
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 09/2008, Volume 14, Issue 34, pp. 5233 - 5236
Journal Article
Cellular Physiology and Biochemistry, ISSN 1015-8987, 10/2017, Volume 42, Issue 5, p. 2144
Journal Article
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 03/2008, Volume 20, Issue 3, pp. 187 - 190
Journal Article